Austin Walne is a Partner with ARTIS Ventures where he invests in biotech, software, and frontier technology, often with a focus on the enterprise and health. He is a board observer at Locus Biosciences. Previously, he was a board director at Stringify and a board observer at Looksharp.

Before ARTIS, he advised institutional investors in the secondary market for private company shares. He also held positions in product management and growth marketing in a variety of technology sectors and was the digital director for a major presidential campaign. He’s been quoted in the following publications on a wide range of topics: The New York Times, The Wall Street Journal, The Washington Post, Bloomberg BusinessWeek, and Inc.

Austin received a Bachelor of Arts degree with a major in Communication Studies from the University of Tennessee and holds FINRA Series 62, 63, 65 licenses.